4 Apr 2018 16:13
e-therapeutics plc
Notice of Annual General Meeting and Annual Report
4 April 2018: e-therapeutics plc (AIM: ETX, "e-therapeutics" or the "Company"), the drug discovery company, announces that its Annual Report and accounts for the year ended 31 January 2018, which includes the notice convening the Company's 2018 Annual General Meeting ("AGM"), can be downloaded from the Company's website at https://www.etherapeutics.co.uk/investors/reports-results/ and will be posted to Shareholders on 6 April 2018.
The 2018 AGM will take place at 11:00 am on 31 May 2018 at the offices of Stephenson Harwood LLP, 1 Finsbury Circus, London EC2M 7SH.
-Ends-
For more information, please contact:
e-therapeutics plc Iain Ross, Chairman Ray Barlow, Chief Executive Officer Steve Medlicott, Finance Director
| Tel: +44 (0)1993 883 125 www.etherapeutics.co.uk
|
Numis Securities Limited Michael Meade / Freddie Barnfield (Nominated Adviser) James Black (Corporate Broking)
| Tel: +44 (0) 207 260 1000 www.numis.com
|
Instinctif Partners Melanie Toyne Sewell / Alex Shaw | Tel: +44 (0) 207 457 2020 Email: e-therapeutics@instinctif.com |
About e-therapeutics plc
e-therapeutics is an Oxford-based company with a unique and powerful computer-based drug discovery platform and specialised approach to network biology.
Its novel methodology and discovery engine allow the Company to discover new and better drugs in a more efficient and effective way.
For more information about the Company, please visit www.etherapeutics.co.uk